AC
Achieve Life Sciences, Inc.
ACHV · NASDAQ
$8.05 +2.16% (+$0.17)
1M +0.50%
Market Cap $747.4M
P/E Ratio -
Div. Yield -
ROE 892.07%
Bulios Fair Price
$4.41
45.2% downside
Trenutna cena
$8.05
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ACHV trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
-
N/A PEG N/A
P/S N/A
P/B N/A
Growth
100 /100
Growing Book val. growth 37.36%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 892.07%
ROA 59.88%
Asset turnover 0.00x
Debt
15 /100
High Int. coverage -113.73x
Current ratio 0.95x
Net debt/EBITDA N/A
Stability
28 /100
Unstable EPS volatility 32.34%
Profitable years 0
Beta 2.25x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ACHV
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew D. Goldberg
Employees
28
Headquarters
Bothell
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report